GlassScriptPhysician profile
Andres M Kanner
NPI 1619963246
$56,705.69
in general payments reported to CMS, 2019-2025
13 companies · $4,363 in 2025
The $4,363 reported for 2025 was more than what 84% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $16K · 2021: $5,240 · 2022: $2,098 · 2023: $9,291 · 2024: $7,118 · 2025: $4,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $3,181 · Food and Beverage: $3,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,413.00 |
| Travel and Lodging | $3,181.17 |
| Food and Beverage | $3,178.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $18,530.73 | 2021-2025 | Valtoco |
| Eisai INC. | $9,988.90 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $7,700.00 | 2020-2021 | |
| Neuropace, INC. | $6,390.37 | 2019-2025 | |
| Eisai Co., LTD. | $3,840.00 | 2020 | |
| Jazz Pharmaceuticals INC. | $3,276.92 | 2022-2025 | |
| Greenwich Biosciences, INC. | $3,157.00 | 2020 | |
| Sk Life Science, INC. | $2,397.45 | 2020 | |
| Medtronic USA, INC. | $1,027.78 | 2019-2020 | |
| Ucb, INC. | $223.87 | 2021-2025 | Fintepla, Briviact |
| Livanova USA, INC. | $124.82 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Ceribell, INC. | $34.71 | 2023-2024 | Pocket Eeg Device, Ceribell Rapid Response Eeg |
| Supernus Pharmaceuticals, INC. | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andres Kanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.